Advertisement

Topics

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg

2014-07-23 21:14:19 | BioPortfolio

Summary

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg.

Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Anxiety

Intervention

Alprazolam Tablets, 2 mg (Geneva Pharmaceuticals, Inc.)

Status

Completed

Source

Sandoz Inc.

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-23T21:14:19-0400

Clinical Trials [1593 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg

To demonstrate the relative bioavailability of Alprazolam tablets, 1 mg.

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 3 mg Alprazolam Extended Release Tablets manufactured and distributed by TEVA Pharmaceuticals USA wi...

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 3 mg Alprazolam Extended Release Tablets manufactured and distributed by TEVA Pharmaceuticals USA wi...

A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety

This was a multicenter, open-label, randomized crossover trial comparing two treatments, Alprazolam ODT versus conventional alprazolam tablets, in subjects who were already taking conventi...

Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets

The objective of the study is to demonstrate the bioequivalence (BE) of two alprazolam 1 mg tablets.

PubMed Articles [2257 Associated PubMed Articles listed on BioPortfolio]

Tablets made from paper.

The possibility to compress ordinary paper into tablets was systematically investigated in this study. Results proved that tablets can be made from paper, independent of the type of paper used. The ta...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

New and miniaturized method for analysis of enrofloxacin in palatable tablets.

Enrofloxacin is an antimicrobial for oral use, from the fluoroquinolones of second-generation class, and it is the first fluoroquinolone used in veterinary for the treatment of bacterial infections. T...

Fabrication of naftopidil-loaded tablets using a semi-solid extrusion-type 3D printer, and the characteristics of the printed hydrogel and resulting tablets.

The production of 3D-printed drugs holds promise for future personalized medicine. Here, we prepared tablets containing naftopidil as a model drug using a semi-solid extrusion-type 3D bioprinter appli...

Inhibition of Gastric H,K-ATPase Activity in Vitro by Dissolution Media of Original Brand-Name and Generic Tablets of Lansoprazole, a Proton Pump Inhibitor.

To investigate the inhibitory effect of a commercial proton pump inhibitor (lansoprazole) on the gastric proton pump H,K-ATPase in vitro, we used orally disintegrating (OD) tablets including original ...

Medical and Biotech [MESH] Definitions

A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)

Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed)

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anesthesia adjuvants. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Anxiety due to fantasized injuries to or loss of the genitals.

Anxiety related to the execution of a task. (Campbell's Psychiatric Dictionary, 9th ed.)

More From BioPortfolio on "To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...


Searches Linking to this Trial